Does hydroxychloroquine improve patient reported outcomes in patients with lupus?
Meenakshi JollyVinay SehgalShilpa AroraDesiree AzizoddinBenzeeta PintoAman SharmaHerve DevilliersMitsuyo InoueSergio TolozaAna BertoliIvana BlazevicLuis M ViláIoana MoldovanKarina D TorralbaDavide MazzoniElvira CicognaniSarfaraz HasniBerna GokerSeminur HaznedarogluJosiane Bourre-TessierSandra V NavarraAnn ClarkeMichael WeismanDaniel WallaceChi Chiu MokPublished in: Lupus (2021)
HCQ use in SLE is associated with better patient reported health outcomes (LupusPRO-HRQOL and NHRQOL and impact on daily life), and the effects are mediated through disease activity. This information can facilitate patients and physician's communication with decision-making regarding the use of HCQ for SLE management.
Keyphrases
- disease activity
- systemic lupus erythematosus
- patient reported outcomes
- patient reported
- rheumatoid arthritis
- rheumatoid arthritis patients
- ankylosing spondylitis
- end stage renal disease
- juvenile idiopathic arthritis
- decision making
- emergency department
- primary care
- ejection fraction
- chronic kidney disease
- prognostic factors
- physical activity
- peritoneal dialysis
- healthcare